Asset Dedication LLC’s Editas Medicine EDIT Stock Holding History

Asset Dedication LLC’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,000	Closed	-$84K	–	772
2020 Q3	$84K	Hold	3,000	–	–	0.02%	291
2020 Q2	$89K	Hold	3,000	–	–	0.02%	271
2020 Q1	$59K	Hold	3,000	–	–	0.02%	297
2019 Q4	$89K	Hold	3,000	–	–	0.03%	247
2019 Q3	$68K	Hold	3,000	–	–	0.02%	256
2019 Q2	$74K	Hold	3,000	–	–	0.02%	251
2019 Q1	$73K	Hold	3,000	–	–	0.03%	244
2018 Q4	$68K	Sell	3,000 -1,500	-33%	-$40.8K	0.03%	235
2018 Q3	$143K	Hold	4,500	–	–	0.05%	171
2018 Q2	$161K	Buy	4,500 +4,400	+4,400%	+$156K	0.06%	162
2018 Q1	$3K	Buy	+100	New	+$3.56K	﹤0.01%	466

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Asset Dedication LLC's EDIT Position: Q4 2020 in Review

Asset Dedication LLC sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 3,000 shares — an estimated $84K sold.

Asset Dedication LLC first reported a position in EDIT in Q1 2018 and held it in 11 quarters. The position peaked at $161K in Q2 2018. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

Asset Dedication LLC reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
Asset Dedication LLC sold 3,000 Editas Medicine shares in Q4 2020, an estimated $84K.
Asset Dedication LLC first reported a position in Editas Medicine in Q1 2018 and held it in 11 quarters.
Asset Dedication LLC's Editas Medicine position peaked at $161K in Q2 2018.
311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Asset Dedication LLC's 13F filing for Q4 2020, filed 28 Jan 2021.